1. Home
  2. TROO vs VNDA Comparison

TROO vs VNDA Comparison

Compare TROO & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TROOPS Inc.

TROO

TROOPS Inc.

N/A

Current Price

$2.60

Market Cap

480.1M

Sector

Technology

ML Signal

N/A

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

N/A

Current Price

$8.61

Market Cap

474.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TROO
VNDA
Founded
2005
2002
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
480.1M
474.0M
IPO Year
2008
2005

Fundamental Metrics

Financial Performance
Metric
TROO
VNDA
Price
$2.60
$8.61
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$14.90
AVG Volume (30 Days)
414.6K
3.6M
Earning Date
01-01-0001
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$216,105,000.00
Revenue This Year
N/A
$21.50
Revenue Next Year
N/A
$38.67
P/E Ratio
N/A
N/A
Revenue Growth
N/A
8.72
52 Week Low
$0.50
$3.81
52 Week High
$5.28
$9.60

Technical Indicators

Market Signals
Indicator
TROO
VNDA
Relative Strength Index (RSI) 38.79 59.84
Support Level $0.89 $4.25
Resistance Level $4.45 $9.35
Average True Range (ATR) 0.40 0.56
MACD -0.09 0.09
Stochastic Oscillator 14.29 86.31

Price Performance

Historical Comparison
TROO
VNDA

About TROO TROOPS Inc.

TROOPS Inc is a conglomerate group of various businesses with its headquarters based in Hong Kong. The group is principally engaged in money lending business in Hong Kong providing mortgage loans to high quality target borrowers, property investment to generate additional rental income and the development, operation and management of an online financial marketplace that provides one-stop financial technology solutions including API services by leveraging artificial intelligence, large data and blockchain, and cloud computing (SaaS). It derives revenue from Hong Kong and Australia. Majority of its revenue generates from domestic market.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: